Investor Presentaiton slide image

Investor Presentaiton

API: Continued strength in regulated markets Key Updates ❖ Pricing pressures and currency challenges in some markets had an adverse impact on demand Regulated markets contribute ~72% of the revenue * Strong portfolio- 8 fillings during the year. (5 USVMF + 3 CEPS) API business now has total 29 USVMFS + 18 CEPS New investment in capacity expansion for leading AH customers * R&D capacity expansion ✰ Comprehensive margin and operations improvement program (Project Pragati ) underway. Benefits to kick in from Q2 FY 24. 1,072 J Sequent Proven Ability In Life Sciences ALIVIRA Commercial APIs 30+ Manufacturing facilities 3 Revenues All values in * Mn 4,565 4,004 4,314 R&D Centre 1 1,118 1,273 941 3,808 Q4 FY20 FY20 Q4 FY21 FY21 Q4 FY22 FY22 Q4 FY23 FY23 Sales to Regulated Markets 70%+ 7
View entire presentation